Pfizer, Inc.

Equities

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse 04:00:21 2024-05-07 pm EDT Pre-market 07:54:30 pm
27.77 USD -1.38% Intraday chart for Pfizer, Inc. 27.39 -1.37%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Pfizer reports patient death in Duchenne gene therapy study RE
BioNTech Swings to First-Quarter Loss as Lower COVID-19 Commercial Sales Dents Topline MT
Pfizer: Citi analyst appointed Chief Strategy Officer CF
Pfizer Names Andrew Baum as Chief Strategy, Innovation Officer MT
Pfizer Names Andrew Baum Chief Strategy, Innovation Officer DJ
BioNTech says 90% of 2024 revenues will accrue at end of year RE
Pfizer Announces Executive Changes CI
Northeast Pharmaceutical's Unit Gets Nod to Produce Azithromycin for Injection MT
GSK plc : Back on track Our Logo
Wall Street: optimism ahead of NFP, rates ease CF
PFIZER INC : Buy rating from DZ Bank ZD
Morgan Stanley Adjusts Price Target on Pfizer to $29 From $28 MT
Leerink Adjusts Price Target on Pfizer to $29 From $27 MT
BMO Capital Adjusts Pfizer's Price Target to $36 From $33, Keeps Outperform Rating MT
Moderna quarterly sales beat expectations but plummet from previous year RE
Morgan Stanley Lifts Price Target on Pfizer to $29 From $28, Keeps Equalweight Rating MT
Health Care Climbs as Pfizer, GSK Rise -- Health Care Roundup DJ
US Equity Markets Close Mixed Wednesday After Fed Holds Rates Steady MT
Sector Update: Health Care Stocks Rise Late Afternoon MT
PFIZER INC : Jefferies gives a Buy rating ZD
Trending : Pfizer 1Q Earnings Top Estimates; Raises FY24 View DJ
Sector Update: Health Care Stocks Advance Wednesday Afternoon MT
News Highlights : Top Company News of the Day - Wednesday at 1 PM ET DJ
Top Midday Stories: CVS Reports Q1 Earnings Miss, Lowers Outlook; ADP Q1 Earnings Top Estimates; J&J Proposes $6.5 Billion Settlement for Talc Lawsuits MT
News Highlights : Top Company News of the Day - Wednesday at 11 AM ET DJ
Chart Pfizer, Inc.
More charts
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.16 USD
Average target price
31.89 USD
Spread / Average Target
+13.26%
Consensus
  1. Stock Market
  2. Equities
  3. PFE Stock
  4. News Pfizer, Inc.
  5. Pfizer Taps Amazon Web Services To Boost Clinical Manufacturing Via Cloud-Based Solutions
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW